WO2026098598 - COMPOUND CONTAINING THREE FUSED HETEROCYCLIC RINGS
National phase entry is expected:
Publication Number
WO/2026/098598
Publication Date
15.05.2026
International Application No.
PCT/CN2025/133247
International Filing Date
07.11.2025
Title **
[English]
COMPOUND CONTAINING THREE FUSED HETEROCYCLIC RINGS
[French]
COMPOSÉ CONTENANT TROIS NOYAUX HÉTÉROCYCLIQUES CONDENSÉS
[Chinese]
含有三并杂环的化合物
Applicants **
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors
REN, Jing
XU, Sheng
DAI, Rongke
WANG, Qinglin
WANG, Jinan
Priority Data
202411595030.1
08.11.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2829 | |
| EPO | Filing, Examination, Granting | 21204 | |
| Japan | Filing, Examination, Granting | 2580 | |
| South Korea | Filing, Examination, Granting | 2965 | |
| USA | Filing, Examination, Granting | 7990 |
Total:
37,568
Contact Us
Abstract[English]
The present application belongs to the field of medicinal chemistry and specifically relates to a compound as shown in formula I, a preparation method therefor, a pharmaceutical composition containing the compound, and the use thereof in the treatment of related diseases (e.g. cancer). PTM-L-CLM I[French]
La présente invention concerne le domaine de la chimie médicale et plus particulièrement un composé tel que représenté dans la formule I, son procédé de préparation, une composition pharmaceutique contenant le composé, et son utilisation dans le traitement de maladies associées (par exemple, le cancer). PTM-1-CLM I[Chinese]
本申请属于医药化学领域，具体涉及式I化合物、其制备方法、含有该化合物的药物组合物、以及其在治疗相关疾病(例如癌症)中的用途。 PTM-L-CLM I